Engineered Immunotherapy Improves Treatment for Brain Cancer - Labroots
AI Briefing
- • Calgary researchers develop promising immunotherapy for solid tumours, including brain cancer.
- • GPNMB CAR-T cells target dual tumour-myeloid interactions in glioblastoma.
- • Experimental treatment reduces rare cancerous tumours, offering new hope for brain cancer patients.
Source Summary
Engineered Immunotherapy Improves Treatment for Brain Cancer Labroots Calgary researchers develop promising immunotherapy for solid tumours CTV News Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells Nature U of C-developed experimental treatment reduces rare cancerous tumours Calgary Herald CAR-T Cell Therapy Eradicates Glioblastoma Neuroscience News
Advertisement